Building confidence at the edge through embedded trust anchors

Tern plc

As digital infrastructure expands across sectors such as healthcare, energy, and manufacturing, the cost of weak or default identities is no longer theoretical. Every unverified connection introduces potential disruption, regulatory risk, and in the most critical environments, threats to safety itself.

Device Authority has placed this foundational challenge at the centre of its Zero Trust strategy. Through its KeyScaler® platform, the company has redefined how identity and policy can be embedded at the edge, directly within the manufacturing and onboarding stages of connected devices. By automating the creation of strong, unique identities tied to secure hardware or generated dynamically where hardware roots of trust do not exist, the system removes the manual processes that often lead to configuration errors and scalability issues. This enables manufacturers and operators to secure fleets of devices from the instant they connect, without human intervention or bottlenecks.

When partnered with Olympus, KeyScaler allows trust anchors to feed directly into enterprise identity and access management systems, ensuring that every device remains under continuous policy governance. Context, behaviour, and health signals can trigger automated responses, from restricted access to complete revocation, ensuring that any anomaly is addressed instantly and proportionately.

Importantly, Device Authority’s approach also acknowledges industrial reality. Many enterprises must work with extensive brownfield environments where legacy assets lack the modern security hardware of new devices. For these cases, KeyScaler’s Dynamic Device Key Generation and Trust on First Use models create strong, software-based identities that can later be reinforced through re-enrolment or attestation.

Tern plc (LON:TERN) backs exciting, high growth IoT innovators in Europe. They provide support and create a genuinely collaborative environment for talented, well-motivated teams.

Share on:
Find more news, interviews, share price & company profile here for:

Latest Company News

AI control of machines creates a new market for device trust

AI is beginning to control physical machines, increasing demand for technology that can verify device identity before those machines are allowed to act.

Peptide drug development expands beyond GLP-1

GLP-1 success is widening interest in peptide drug development, with the next phase focused on proving clinical value across new therapeutic areas.

Tern Plc announces 90% take-up of Open Offer

Tern Plc has received valid acceptances for 50.9 million Open Offer Shares, representing approximately 90% of the shares available. The fully underwritten offer will raise approximately £509,368 before expenses, with admission of the new shares expected on 24 September 2026.

Talking Medicines moves to capture pharma demand for better patient intelligence

Tighter US pharma advertising rules could increase demand for patient intelligence, supporting the relevance of Talking Medicines’ DrugVoice platform.

Tern portfolio company Talking Medicines launches ‘Intent to Prescribe’ DrugVoice application

Talking Medicines has launched a new DrugVoice application combining its Message Resonance Score™ with near-real-time point-of-care data to help pharmaceutical companies assess links between HCP message alignment and prescribing intent.

Device Authority targets secure digital infrastructure for smart ports

Device Authority's Smart, Green Port Blueprint shows how secure device management can support the wider rollout of connected infrastructure across modern ports.

Search